Grimes & Company’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
6,341
+814
+15% +$37.7K 0.01% 384
2026
Q1
$271K Buy
5,527
+247
+5% +$11.5K 0.01% 373
2025
Q4
$230K Buy
5,280
+80
+2% +$3.65K 0.01% 421
2025
Q3
$234K Buy
5,200
+47
+0.9% +$2.06K 0.01% 416
2025
Q2
$224K Buy
5,153
+102
+2% +$4.54K 0.01% 391
2025
Q1
$233K Buy
+5,051
New +$211K 0.01% 327
2023
Q1
Sell
-4,724
Closed -$204K 308
2022
Q4
$204K Buy
+4,724
New +$187K 0.01% 268
2022
Q3
Sell
-4,667
Closed -$212K 273
2022
Q2
$212K Hold
4,667
0.01% 254
2022
Q1
$222K Sell
4,667
-1,652
-26% -$70K 0.01% 274
2021
Q4
$260K Hold
6,319
0.01% 259
2021
Q3
$218K Sell
6,319
-3,126
-33% -$107K 0.01% 275
2021
Q2
$299K Hold
9,445
0.01% 241
2021
Q1
$295K Sell
9,445
-900
-9% -$27K 0.01% 232
2020
Q4
$312K Sell
10,345
-31
-0.3% -$915 0.02% 216
2020
Q3
$265K Hold
10,376
0.02% 214
2020
Q2
$269K Buy
+10,376
New +$275K 0.02% 208
2020
Q1
Sell
-6,871
Closed -$223K 243
2019
Q4
$223K Buy
6,871
+701
+11% +$22.7K 0.01% 243
2019
Q3
$213K Hold
6,170
0.02% 236
2019
Q2
$211K Hold
6,170
0.02% 232
2019
Q1
$221K Buy
+6,170
New +$210K 0.02% 227
2014
Q4
Sell
-9,778
Closed -$238K 168
2014
Q3
$238K Sell
9,778
-1
-0% -$23 0.06% 129
2014
Q2
$254K Hold
9,779
0.07% 132
2014
Q1
$234K Buy
+9,779
New +$206K 0.07% 129
2013
Q4
Sell
-9,562
Closed -$202K 144
2013
Q3
$202K Sell
9,562
-349
-4% -$7.63K 0.07% 126
2013
Q2
$218K Buy
+9,911
New +$240K 0.08% 109

Other funds holding EXC

Grimes & Company's EXC Position: Q2 2026 in Review

Grimes & Company increased its Exelon (EXC) stake by 15% in Q2 2026, buying an estimated $37.7K and bringing the position to 6,341 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #384.

Grimes & Company first reported a position in EXC in Q2 2013 and has held it in 25 quarters since. The position peaked at $312K in Q4 2020. 510 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Grimes & Company held 6,341 shares of Exelon worth $296K as of Q2 2026.
  • Grimes & Company bought 814 Exelon shares in Q2 2026, an estimated $37.7K.
  • Exelon made up 0.01% of Grimes & Company's portfolio in Q2 2026, its #384 holding.
  • Grimes & Company first reported a position in Exelon in Q2 2013 and has held it in 25 quarters since.
  • Grimes & Company's Exelon position peaked at $312K in Q4 2020.
  • 510 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.